Irès van der Zwaan is currently doing an industrial Postdoc in inhaled drug delivery at AstraZeneca, Gothenburg, in collaboration with Université Catholique de Louvain, Brussels. In this project her research is focused on the influence of formulation on protein aggregation of inhaled biologics in vivo. Prior to this, Irès obtained her PhD in Pharmaceutical Sciences from Uppsala University within the Swedeliver research center. During her PhD she worked on the characterisation of an in vitro dissolution method for assessment of novel pulmonary drug delivery systems.
